Coherus Oncology
CHRS
CHRS
122 hedge funds and large institutions have $842M invested in Coherus Oncology in 2016 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 44 increasing their positions, 37 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% more capital invested
Capital invested by funds: $741M → $842M (+$101M)
4% more funds holding
Funds holding: 117 → 122 (+5)
92% less call options, than puts
Call options by funds: $268K | Put options by funds: $3.3M
Holders
122
Holding in Top 10
3
Calls
$268K
Puts
$3.3M
Top Buyers
| 1 | +$16.9M | |
| 2 | +$13.6M | |
| 3 | +$11.3M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$7.22M |
| 5 |
JCG
JHL Capital Group
Chicago,
Illinois
|
+$7.04M |
Top Sellers
| 1 | -$13.5M | |
| 2 | -$10.3M | |
| 3 | -$8.84M | |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$5.22M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.99M |